Limited impact of short-term disruptions, growth momentum to continue in FY 23
Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities
Large players are adequately capitalised to make bigger investments to adjust for the ongoing fundamental shift in market opportunities
Circular revenues already at 16% of sales, driven by healthcare informatics and services to enhance medical equipment uptime and utilization, system and software upgrades for enhanced functionality and extended lifetime and reusing refurbished parts and systems
Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline
It will open new frontier for south-to-south collaboration and innovation transfer
EBITDA from Continuing Operations at Rs. 582 crore recorded a growth of 31 %.
Unlike most data analysis services, Dolomite Bio will accept sample sizes ranging from as little as one sample, to as many as the research project requires
Emergency Use Authorisation application request to be submitted following one month required by FDA EUA guidance
All the recommendations have been sent to the Drugs Controller General of India (DCGI) for final approval.
Trastuzumab is monoclonal antibody used to treat human epidermal growth factor receptor 2 positive (HER2+) breast cancer and metastatic gastric cancers
In Japan, breast cancer is the most common cancer in women, with approximately 92,000 cases of breast cancer diagnosed in 2020
Subscribe To Our Newsletter & Stay Updated